Stoke Therapeutics, Inc. (STOK) Insider Trading -- Recent Executive & Director Transactions

12 insiders reported 136 Form 4 transactions for Stoke Therapeutics, Inc. (STOK) over the past 18 months (most recent 2026-07-06). Recent activity: Ticho Barry (CHIEF MEDICAL OFFICER) Sell 500 shares, Ticho Barry (CHIEF MEDICAL OFFICER) Sell 6,728 shares, Allan Jonathan (GENERAL COUNSEL & CORP SEC) Sell 1,457 shares, Ticho Barry (CHIEF MEDICAL OFFICER) Sell 1,795 shares, Ticho Barry (CHIEF MEDICAL OFFICER) Sell 1,838 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-07-06Ticho BarryCHIEF MEDICAL OFFICERSell500$16,634
2026-07-06Ticho BarryCHIEF MEDICAL OFFICERSell6,728$219,434
2026-06-18Allan JonathanGENERAL COUNSEL & CORP SECSell1,457$43,637
2026-06-03Ticho BarryCHIEF MEDICAL OFFICERSell1,795$54,891
2026-04-03Ticho BarryCHIEF MEDICAL OFFICERSell1,838$60,029
2026-03-24Allan JonathanGENERAL COUNSEL & CORP SECSell8,692$292,399
2026-03-24Allan JonathanGENERAL COUNSEL & CORP SECSell601$20,680
2026-03-19Hoitt JasonChief Patient OfficerSell139$4,419
2026-03-19Ticho BarryCHIEF MEDICAL OFFICERSell2,587$86,354
2026-03-19Ticho BarryCHIEF MEDICAL OFFICERSell6,100$190,808
2026-03-19Ticho BarryCHIEF MEDICAL OFFICERSell483$15,355
2026-03-19Ticho BarryCHIEF MEDICAL OFFICERSell103$3,384
2026-03-19Ticho BarryCHIEF MEDICAL OFFICERBuy1,365$2,989
2026-03-19Ticho BarryCHIEF MEDICAL OFFICERSell3,577$117,111
2026-03-19Leggett ThomasChief Financial OfficerSell1,274$41,711
2026-03-19Leggett ThomasChief Financial OfficerSell922$30,776
2026-03-19Leggett ThomasChief Financial OfficerSell2,173$67,971
2026-03-19Leggett ThomasChief Financial OfficerSell172$5,468
2026-03-19Leggett ThomasChief Financial OfficerSell37$1,215
2026-03-19Hoitt JasonChief Patient OfficerSell1,033$33,820
2026-03-19Hoitt JasonChief Patient OfficerSell748$24,968
2026-03-19Hoitt JasonChief Patient OfficerSell1,762$55,115
2026-03-19Ticho BarryCHIEF MEDICAL OFFICERSell1,461$43,815
2026-03-19Hoitt JasonChief Patient OfficerSell30$986
2026-03-19Allan JonathanGENERAL COUNSEL & CORP SECSell2,476$81,064

Source: SEC Form 4 filings · as of 2026-07-06